A1 Control LLC
License fiscal year: 2018
Ohio State primary inventor(s): Eileen Faulds
College: Wexner Medical Center
Department: University Hospitals
Leadership: Carl Noble
Ownership status: Privately held
Headquarters: Lewis Center, OH
Description: Glucose monitoring and control systems, such as the “artificial pancreas,” are complex devices able to precisely and continuously control insulin levels. Despite their superior technology, the use of such devices by patients at home may be limited due to the difficulty in providing appropriate and effective training tools. A1 Control is developing an engaging, game-like computer application for patients who must use sophisticated glucose monitoring devices to treat diabetes mellitus. The application will assess the patient’s current level of knowledge, provide personalized education more quickly and cost-efficiently than current approaches, and provide feedback to therapy providers regarding patient performance – facilitating greater use of the state-of- the-art glucose monitoring technology.